MRK Preview Mode — Vezi un preview — analiza completa cu Strategy Signals, Smart Money 13F si Insider Trades disponibila cu cont. Sign Up Free → sau Login
📡 SignalRadar — RadarScope
Merck & Co., Inc.
MRK NYSE Healthcare Drug Manufacturers - General
$128.41
1M: +12.4% | 3M: +7.6%
Calitate
Q9
Risc
R3
Scor AI
50
Verdict
TINE
Market Cap
$317.2B
P/E Ratio
36.1
Profit Margin
13.6%
ROE
17.9%
📈 Earnings Report — 2026-04
Ultimul trimestru raportat
EPS Actual
$-1.28
▼ 162.7% QoQ▼ 157.7% YoY
EPS Estimat
$-1.47
Beat by 12.9%
Revenue Actual
$16.29B
▼ 0.7% QoQ▲ 4.9% YoY
Revenue Estimat
$15.85B
Beat by 2.8%
Istoric Ultimele 4 Trimestre
2026-04
EPS Actual
$-1.28
EPS Est.
$-1.47
Revenue
$16.29B
Beat/Miss
Beat by 12.9%
2026-02
EPS Actual
$2.04
EPS Est.
$2.01
Revenue
$16.40B
Beat/Miss
Beat by 1.5%
2025-10
EPS Actual
$2.58
EPS Est.
$2.36
Revenue
$17.28B
Beat/Miss
Beat by 9.3%
2025-07
EPS Actual
$2.13
EPS Est.
$2.03
Revenue
$15.81B
Beat/Miss
Beat by 4.9%
Urmatorul Raport
Data
2026-10-29
EPS Estimat
$2.3
Revenue Estimat
$17.34B
💰 Dividende Recente
2026-06
$0.85
Yield: 292.43%
Plata: 2026-07
2026-03
$0.85
Yield: 287.62%
Plata: 2026-04
2025-12
$0.85
Yield: 327.15%
Plata: 2026-01
2025-09
$0.81
Yield: 399.9%
Plata: 2025-10
📊 Scoruri Companie
Crestere 9/10
9
Revenue & Profit Growth
Evaluare 5/10
5
P/E · P/B · P/S
Calitate 9/10
9
Marje · ROE · Datorii
Risc 3/10
3
Beta · Market Cap
📈 Date Financiare Istorice in miliarde USD
💰 Revenue
📊 Net Profit
💵 Cash Flow
Operating (albastru) · Free (violet)
🏦 Cash & Datorii
Cash (verde) · Long-term Debt (rosu)
💸 Operating Expenses
🤖 Analiza RadarScope AI
Analiza indisponibila temporar.
💡 Vezi datele de mai jos
🐂 BULL CASE
Date financiare solide
Pozitie competitiva puternica
🐻 BEAR CASE
Evaluare ridicata
Incertitudine macro
TINE Analiza manuala recomandata
📊 Metrici Fundamentale
P/E TTM36.1
P/B TTM6.92
P/S TTM4.84
EV/EBITDA
Gross Margin75.9%
Operating Margin27.6%
Net Margin13.6%
ROE17.9%
ROA6.9%
Debt/Equity
Current Ratio1.30
FCF Yield4.5%
Dividend Yield2.6%
Beta0.22
💰 Venituri & Profit (ultimele trimestre)
TrimestruRevenueGross ProfitNet IncomeEPS
2025-12$64.9B$46.7B$18.3B$7.30
2024-12$64.2B$49.0B$17.1B$6.76
2023-12$60.1B$44.0B$365.0M$0.14
2022-12$59.3B$41.9B$14.5B$5.73
🏢 Profil Companie
CEORobert Davis
Angajati73000
IPO1978-01-13
52W High$130.29
52W Low$76.66
Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhil...
🎯 Score Breakdown
Calitate Companie (Q) 9/10
Risc Speculativ (R) 3/10
Scor AI RadarScope 50/100
VERDICT FINAL
TINE
Analiza manuala recomandata
🤖 Chat AI — Intreaba despre MRK
RadarScope AI
Buna! Pot raspunde la orice intrebare despre MRK. Ce vrei sa stii?

🔒 Analiza completa disponibila cu cont SignalRadar

Vezi Strategy Signals AI (Triple Oversold, BB Squeeze), Smart Money 13F ($837 mld Berkshire+BlackRock+Vanguard), Insider Trades live SEC Form 4, News + Short Interest in timp real, 20+ indicatori tehnici Multi-TF.

🚀 Cont Gratuit (25 tickere) Vezi planurile platite (de la $4.99)
+ 13F Smart Money+ Form 4 Insider+ TA MEGA 20+ indicatori+ AI Signals Triple Oversold etc.+ Multi-TF 1D/1W/1M
[!] Datele sunt informative. NU constituie sfat investitional personalizat. Decizia de investitie iti apartine. Detalii